Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Genes Chromosomes Cancer
; 63(2): e23226, 2024 02.
Article
en En
| MEDLINE
| ID: mdl-38380774
ABSTRACT
Epithelioid hemangioendothelioma (EHE) is a rare endothelial sarcoma associated with a high incidence of metastases and for which there are no standard treatment options. Based on disease-defining mutations, most EHEs are classified into two subtypes WWTR1CAMTA1-fused EHE or YAP1TFE3-fused EHE. However, rare non-canonical fusions have been identified in clinical samples of EHE cases and are challenging to classify. In this study, we report the identification of a novel WWTR1TFE3 fusion variant in an EHE patient using targeted RNA sequencing. Histologically, the tumor exhibited hybrid morphological characteristics between WWTR1CAMTA1-fused EHE and YAP1TFE3-fused EHE. In addition to the driver fusion, there were six additional secondary mutations identified, including a loss-of-function FANCA mutation. Furthermore, in vitro studies were conducted to investigate the tumorigenic function of the WWTR1TFE3 fusion protein in NIH3T3 cells and demonstrated that WWTR1TFE3 promotes colony formation in soft agar. Finally, as the wild-type WWTR1 protein relies on binding the TEAD family of transcription factors to affect gene transcription, mutation of the WWTR1 domain of the fusion protein to inhibit such binding abrogates the transformative effect of WWTR1TFE3. Overall, we describe a novel gene fusion in EHE with a hybrid histological appearance between the two major genetic subtypes of EHE. Further cases of this very rare subtype of EHE will need to be identified to fully elucidate the clinical and pathological characteristics of this unusual subtype of EHE.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Transactivadores
/
Hemangioendotelioma Epitelioide
Límite:
Animals
/
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article